Trial By Error: The UK’s Proposed Genetics Study
By David Tuller, DrPH In the UK, leading researchers are preparing to submit an application for a large genetic study to two major funding agencies. The project is being led…
By David Tuller, DrPH In the UK, leading researchers are preparing to submit an application for a large genetic study to two major funding agencies. The project is being led…
By David Tuller, DrPH Since 2008, the National Health Service (NHS) in England has been rolling out a program known as Improving Access to Psychological Therapies (IAPT). Initially focused on…
By David Tuller, DrPH Had things gone as planned, the PACE trial should have been able to serve as proof that so-called medically unexplained symptoms (MUS), in this case what…
By David Tuller, DrPH On January 10th, the following information was announced in a press release: Mahana Therapeutics, a digital therapeutics company reimagining the treatment of chronic diseases, today announced…
By David Tuller, DrPH As I wrote yesterday, Mahana Therapeutics has recently licensed from King’s College London an “innovative digital therapeutic”, a web-based program delivering a course of cognitive behavioral…
By David Tuller, DrPH When I was in Australia two years ago–wow, can’t believe it’s been that long!–I spent some time with Dr Mark Guthridge, an associate professor of biomedical…